P

Inventor

GILLESPIE ROGER JOHN

GB32 patents
⚠️ This page may combine multiple inventors who share the name “GILLESPIE ROGER JOHN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

VERNALIS RES LTD

16 patents
US6787541B1Sep 7, 2004

Thieno-and furopyrimidine derivatives as A2A-receptor antagonists

VERNALIS RES LTD64 citations95
US7405219B2Jul 29, 2008

Triazolo [4,5-d] pyrimidine derivatives and their use as purinergic receptor antagonists

VERNALIS RES LTD44 citations94
US7141575B2Nov 28, 2006

Triazolo[4,5-d]pyrimidine derivatives and their use as purinergic receptor antagonists

VERNALIS RES LTD45 citations94
US6608085B1Aug 19, 2003

4-quinolinemethanol derivatives as purine receptor antagonists (II)

VERNALIS RES LTD55 citations91
US7589097B2Sep 15, 2009

Triazol[4,5-d] pyramidine derivatives and their use as purinergic receptor antagonists

VERNALIS RES LTD18 citations90
US6828318B2Dec 7, 2004

2-adamantylethylamines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission

VERNALIS RES LTD48 citations89
US6583156B1Jun 24, 2003

4-Quinolinemethanol derivatives as purine receptor antagonists (1)

VERNALIS RES LTD33 citations89
US7384949B2Jun 10, 2008

Thieno(3,2-d)pyrimidines and furano(3,2-d)pyrimidines and their use as purinergic receptor antagonists

VERNALIS RES LTD10 citations82
US7629349B2Dec 8, 2009

Pyrazolo [3,4-d] pyrimidine derivatives and their use as purinergic receptor antagonists

VERNALIS RES LTD4 citations62
US7098333B2Aug 29, 2006

Pyrrolo[2,3-d]pyrimidine and their use as purinergic receptor antagonists

VERNALIS RES LTD2 citations62
US7087754B2Aug 8, 2006

Pyrazolo[3,4-d]pyrimidine derivatives and their use as purinergic receptor antagonists

VERNALIS RES LTD5 citations62
US7452894B2Nov 18, 2008

Purine derivatives as purinergic receptor antagonists

VERNALIS RES LTD2 citations60
US6531511B1Mar 11, 2003

2-adamantanemethanamine compounds for treating abnormalities in glutamatergic transmission

VERNALIS RES LTD2 citations58
US6262106B1Jul 17, 2001

Adamantanecarboximidamide derivatives and their use as NMDA antagonists

VERNALIS RES LTD3 citations57
US6500866B1Dec 31, 2002

1-(adamantyl)amidines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission

VERNALIS RES LTD2 citations56
US7598256B2Oct 6, 2009

Pyrrolo [2,3-d] pyrimidine and their use as purinergic receptor antagonists

VERNALIS RES LTD0 citations51

VERNALIS R&D LTD

8 patents

VERTEX PHARMA

6 patents

BAMFORD SAMANTHA JANE

1 patent

BATCHELOR MARK JAMES

1 patent